The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Primary and secondary glioblastomas: From concept to clinical diagnosis
Open accessAbstract
Glioblastomas may develop de novo (primary glioblastomas) or through progression from low-grade or anaplastic astrocytomas, (secondary glioblastomas). These subtypes of glioblastoma constitute distinct disease entities that evolve through different genetic pathways, affect patients at different ages, and are likely to differ in prognosis and response to therapy. Primary glioblastomas develop in older patients and typically show EGFR overexpression, PTEN (MMAC1) mutations, CDKN2A (p16) deletions, and less frequently, MDM2 amplification. Secondary glioblastomas develop in younger patients and often contain TP53 mutations as the earliest detectable alteration. These characteristics are derived largely from patients selected on the basis of clinical history and sequential biopsies. Currently available data are insufficient for a substitution of histologic classification and grading of astrocytic tumors by genetic typing alone. More subtypes of glioblastomas may exist with intermediate clinical and genetic profiles, a factor exemplified by the giant-cell glioblastoma that clinically and genetically occupies a hybrid position between primary (de novo) and secondary glioblastomas. Future research should aim at the identification of criteria for a combined clinical, histologic, and genetic classification of astrocytic tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Pathology of Tumours of the Nervous System
(1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199001000-00011 · Cited by 3,472
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
The multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853
— Tumors of the Central Nervous System
(2013) · Pediatric Radiotherapy Planning and Treatment · doi:10.1201/b14554-7 · Cited by 1,751
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“The putative tumor suppressor p19 blocks MDM2-induced degradation and transactivational silencing of p53 (Pomerantz et al., 1998; Zhang et al., 1998).”
BackgroundLibermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., & Schlessinger, J. (1985) · Nature · doi:10.1038/313144a0 · Cited by 1,503
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Self-citationPLATELET-DERIVED GROWTH FACTOR
Ross, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92760-8 · Cited by 940
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00848.x · Cited by 740
Self-citationClonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Sugawa, N., Ekstrand, A. J., James, C. D., & Collins, V. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8602 · Cited by 594
Platelet-derived growth factor receptor signals.
Claesson-Welsh, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31591-6 · Cited by 561
Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., & Collins, V. P. (1993) · PubMed · Cited by 560
Landscaping the Cancer Terrain
Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.280.5366.1036 · Cited by 516
(1997) · PubMed · Cited by 512
Platelet-derived growth factor: mechanism of action and possible in vivo function.
Heldin, C. H., & Westermark, B. (1990) · Cell Regulation · doi:10.1091/mbc.1.8.555 · Cited by 486
Ojeda, V. J. (1988) · Pathology · doi:10.1016/s0031-3025(16)36608-9 · Cited by 418
THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE
SCHERER, H. J. (1940) · Brain · doi:10.1093/brain/63.1.1 · Cited by 408
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
Burger, P. C., & Green, S. B. (1987) · Cancer · doi:10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x · Cited by 391
PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
Rasheed, B., Stenzel, T. T., McLendon, R. E., Parsons, R. E., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Bigner, S. H. (1997) · PubMed · Cited by 388
PTEN mutations in gliomas and glioneuronal tumors
Duerr, E.-M., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer-Puttlitz, B., Louis, D. N., Schramm, J., Wiestler, O. D., Parsons, R., Eng, C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201756 · Cited by 344
Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis
von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., & Louis, D. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00721.x · Cited by 331
Barak, Y., Gottlieb, E., Juven-Gershon, T., & Oren, M. (1994) · Genes & Development · doi:10.1101/gad.8.15.1739 · Cited by 328
Structural Development in Gliomas
Scherer, H.-J. (1938) · American Journal of Cancer · doi:10.1158/ajc.1938.333 · Cited by 314
The p53 Gene and Protein in Human Brain Tumors
Louis, D. N. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199401000-00002 · Cited by 300
Lang, F. F., Miller, D. C., Koslow, M., & Newcomb, E. W. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.81.3.0427 · Cited by 300
Supratentorial anaplastic gliomas in adults
Winger, M. J., Macdonald, D. R., & Cairncross, J. G. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.71.4.0487 · Cited by 293
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas
Nelson, J. S., Tsukada, Y., Schoenfeld, D., Fulling, K., Lamarche, J., & Peress, N. (1983) · Cancer · doi:10.1002/1097-0142(19830801)52:3<550::aid-cncr2820520327>3.0.co;2-c · Cited by 276
A functional p53-responsive intronic promoter is contained within the human mdm2 gene
Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., & Oren, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2584 · Cited by 276
Sigalas, I., Calvert, A. H., Anderson, J. J., Neal, D. E., & Lunec, J. (1996) · Nature Medicine · doi:10.1038/nm0896-912 · Cited by 268
Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00005 · Cited by 256
Self-citation(1997) · PubMed · Cited by 256
Hermanson, M., Funa, K., Koopmann, J., Maintz, D. C., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A., et al. (1996) · PubMed · Cited by 255
Molecular pathways in the formation of gliomas
von Deimling, A., Louis, D. N., & Wiestler, O. D. (1995) · Glia · doi:10.1002/glia.440150312 · Cited by 245
(1994) · PubMed · Cited by 244
Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors
Louis, D. N., Deimling, A. V., Chung, R. Y., Rubio, M.-P., Whaley, J. M., Eibl, R. H., Ohgaki, H., Wiestler, O. D., Thor, A. D., & Seizinger, B. R. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199301000-00005 · Cited by 228
Self-citationvon Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Hoell, T., Chung, R. Y., Martuza, R. L., Schoenfeld, D. A., Yaşargil, M. G., Wiestler, O. D., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0295 · Cited by 218
von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Wiestler, O., & Seizinger, B. R. (1992) · PubMed · Cited by 210
Picksley, S. M., & Lane, D. P. (1993) · BioEssays · doi:10.1002/bies.950151008 · Cited by 207
A Molecular Genetic Model of Astrocytoma Histopathology
Louis, D. N. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb01062.x · Cited by 199
Boström, J. P., Cobbers, J. M. J. L., Wolter, M., Tabatabai, G., Weber, R. G., Lichter, P., Collins, V. P., & Reifenberger, G. (1998) · PubMed · Cited by 194
A CRITICAL REVIEW: THE PATHOLOGY OF CEREBRAL GLIOMAS
Scherer, H. J. (1940) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.3.2.147 · Cited by 191
Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson, D. C., Maréchal, V., Momand, J. A., Chen, J., Romocki, C., & Levine, A. J. (1993) · PubMed · Cited by 188
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed, B., McLendon, R. E., Friedman, H. S., Friedman, A. H., Fuchs, H. E., Bigner, D. D., & Bigner, S. H. (1995) · PubMed · Cited by 183
Effects of Colchicine and Radiation on Growth of Normal Tissues and Tumors
Brues, A. M., Marble, B. B., & Jackson, E. B. (1940) · American Journal of Cancer · doi:10.1158/ajc.1940.159 · Cited by 183
Newcomb, E. W., Cohen, H., Lee, S. R., Bhalla, S. K., Bloom, J., Hayes, R. L., & Miller, D. C. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00191.x · Cited by 179
Amplification and Overexpression of MDM2 in Primary (de novo) Glioblastomas
BIERNAT, W., KLEIHUES, P., YONEKAWA, Y., & OHGAKI, H. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00009 · Cited by 178
Self-citationBiochemical properties and biological effects of p53
Haffner, R., & Oren, M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90058-6 · Cited by 175
Prigent, S. A., Nagane, M., Lin, H., Huvar, I., Boss, G. R., Feramisco, J. R., Cavenee, W. K., & Huang, H.-J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25639 · Cited by 175
Reifenberger, J., Ring, G. U., Gies, U., Ludwig Cobbers, J. M. J., Oberstrab, J., An, H.-X., Niederacher, D., Wechsler, W., & Reifenberger, G. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199607000-00007 · Cited by 172
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
Biernat, W., Tohma, Y., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050711 · Cited by 166
Self-citationGene amplification in human gliomas
Collins, V. P. (1995) · Glia · doi:10.1002/glia.440150309 · Cited by 160
Necrosis as a prognostic factor in glioblastoma multiforme
Barker, F. G., Davis, R. L., Chang, S. M., & Prados, M. D. (1996) · Cancer · Cited by 152
Genetic alterations associated with the evolution and progression of astrocytic brain tumours
Ohgaki, H., Kleihues, P., Schäuble, B., Hausen, A. Z., & von Ammon, K. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00196514 · Cited by 129
Self-citationAssociation of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme
Hayashi, Y., Ueki, K., Waha, A., Wiestler, O. D., Louis, D. N., & von Deimling, A. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00890.x · Cited by 128
Molecular Genetic Correlates of p16, cdk4, and pRb Immunohistochemistry in Glioblastomas
Burns, K. L., Ueki, K., Jhung, S., Koh, J., & Louis, D. N. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199802000-00003 · Cited by 120
A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme
Newcomb, E. W., Madonia, W. J., Pisharody, S., Lang, F. F., Koslow, M., & Miller, D. C. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00749.x · Cited by 118
Current Concepts in Neuro-Oncology: The Cell Cycle-A Review
Dirks, P. B., & Rutka, J. T. (1997) · Neurosurgery · doi:10.1097/00006123-199705000-00025 · Cited by 116
Role of gemistocytes in astrocytoma progression.
Watanabe, K., Tachibana, O., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1997) · PubMed · Cited by 110
Self-citationDeletion mapping of the long arm of chromosome 10 in glioblastoma multiforme
Fults, D., & Pedone, C. A. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070311 · Cited by 107
Molecular genetic analysis of giant cell glioblastomas.
Meyer‐Puttlitz, B., Hayashi, Y., Waha, A., Rollbrocker, B., Boström, J. P., Wiestler, O. D., Louis, D. N., Reifenberger, G., & von Deimling, A. (1997) · Europe PMC (PubMed Central) · Cited by 103
The tumor suppressor protein p53
Hainaut, P. L. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199501000-00012 · Cited by 97
Matsumoto, R., Tada, M., Nozaki, M., Zhang, C. L., Sawamura, Y., & Abe, H. (1998) · PubMed · Cited by 97
van Meyel, D. J., Ramsay, D. A., Casson, A. G., Keeney, M., Chambers, A. F., & Cairncross, J. G. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.13.1011 · Cited by 96
Korkolopoulou, P., Christodoulou, P., Kouzelis, K., Hadjiyannakis, M., Priftis, A., Stamoulis, G., Seretis, A., & Thomas-Tsagli, E. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.216 · Cited by 95
Deletion mapping of chromosome 19 in human gliomas
von Deimling, A., Nagel, J., Bender, B., Lenartz, D., Schramm, J., Louis, D. N., & Wiestler, O. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570511 · Cited by 89
Two tumor suppressive loci on chromosome 10 involved in human glioblastomas
Steck, P. A., Ligon, A. H., Cheong, P. Y. Y., Yung, W. K. A., & Pershouse, M. A. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120404 · Cited by 84
Genetics of Glioma Progression and the Definition of Primary and Secondary Glioblastoma
Kleihues, P., & Ohgaki, H. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00993.x · Cited by 79
Self-citationAlbarosa, R., Colombo, B. M., Roz, L., Magnani, I., Pollo, B., Cirenei, N., Giani, C., Conti, A. M. F., DiDonato, S., & Finocchiaro, G. (1996) · PubMed · Cited by 78
Necrogenesis and Fas/APO-1 (CD95) Expression in Primary (de novo) and Secondary Glioblastomas
Tohma, Y., Gratas, C., Meir, E. G. V., Desbaillets, I., Tenan, M., Tachibana, O., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199803000-00005 · Cited by 72
Self-citationp53 Mutations versus EGF Receptor Expression in Giant Cell Glioblastomas
Peraud, A., Watanabe, K., Plate, K. H., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00008 · Cited by 65
Self-citationMutations of theINK4aLocus in Squamous Cell Carcinomas of Human Skin
Kubo, Y., Urano, Y., Matsumoto, K., Ahsan, K., & Arase, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6217 · Cited by 61
p53 immunoreactivity in astrocytomas and its relationship to survival
Al‐Sarraj, S., & Bridges, L. (1995) · British Journal of Neurosurgery · doi:10.1080/02688699550041476 · Cited by 41
Shiohara, M., Spirin, K. S., Said, J. W., Gombart, A., Nakamaki, T., Takeuchi, S., Hatta, Y., Roberta Morosetti, A., Tasaka, T., Seriu, T., et al. (1996) · PubMed · Cited by 22
Recent advances in the biology of central nervous system tumors
Ashley, D. M., & Bigner, D. D. (1997) · Current Opinion in Neurology · doi:10.1097/00019052-199712000-00002 · Cited by 8
Cited by
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The WHO classification of tumors of the nervous system
Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,547
Self-citationCost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
Giese, A., Bjerkvig, R., Berens, M. E., & Westphal, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.063 · Cited by 1,200
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Metadata
- Authors
- Kleihues, P., & Ohgaki, H.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 44-51
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2114292508
- Cited by
- 586
- References
- 84
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.